Stop-gain mutations in PKP2 are associated with a later age of onset of arrhythmogenic right ventricular cardiomyopathy.
<h4>Background</h4>Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a cardiac disease characterized by the presence of fibrofatty replacement of the right ventricular myocardium, which may cause ventricular arrhythmias and sudden cardiac death. Pathogenic mutations in several ge...
Saved in:
Main Authors: | Mireia Alcalde, Oscar Campuzano, Paola Berne, Pablo García-Pavía, Ada Doltra, Elena Arbelo, Georgia Sarquella-Brugada, Anna Iglesias, Luis Alonso-Pulpon, Josep Brugada, Ramon Brugada |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/056fba4deb9c4634a5510ddfb55b9c74 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy
by: Ryan Wallace, et al.
Published: (2021) -
Arrhythmogenic Right Ventricular Cardiomyopathy in Pediatric Patients: An Important but Underrecognized Clinical Entity
by: Anneline S. J. M. te Riele, et al.
Published: (2021) -
Arrhythmogenic right ventricular cardiomyopathy in patients with biallelic JUP-associated skin fragility
by: Hassan Vahidnezhad, et al.
Published: (2020) -
Featuring: Josep Brugada
by: Josep Brugada
Published: (2019) -
Desmosomal cadherins are decreased in explanted arrhythmogenic right ventricular dysplasia/cardiomyopathy patient hearts.
by: Alexia Vite, et al.
Published: (2013)